ACM
ORKA

Aster Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Aster Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.99K Buy
+105
New +$7K ﹤0.01% 664
2026
Q1 		– Sell
-25
Closed -$758 – 1420
2025
Q4 		$758 Buy
+25
New +$697 ﹤0.01% 1015
2025
Q1 		– Sell
-5
Closed -$97 – 1738
2024
Q4 		$97 Buy
+5
New +$122 ﹤0.01% 1071

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Aster Capital Management's ORKA Position: Q2 2026 in Review

Aster Capital Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 105 shares worth $9.99K. The stake represents ﹤0.01% of the portfolio and ranks #664 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in ORKA as recently as Q4 2025.

Aster Capital Management first reported a position in ORKA in Q4 2024 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Aster Capital Management held 105 shares of Oruka Therapeutics worth $9.99K as of Q2 2026.
  • Oruka Therapeutics was a new Aster Capital Management position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #664 holding.
  • Aster Capital Management first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.